Design
Review
Authors
Loading...
Identifies C/EBPbeta as a potential anti-inflammatory target; leaves open relevance to cardiovascular outcomes.
Recent studies provide new insight into the pharmacological actions of aspirin and salicylate, implicating C/EBPbeta as a potential target for inflammation and tissue injury therapy.
Kenneth K. Wu (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: